| Advanced Biomed Inc. (ADVB) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q4-CY2026 | Q3-CY2026 | Q2-CY2026 | Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | |
| Balance Sheet Date | 2026-Jun-30 | 2026-Mar-31 | 2025-Dec-31 | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | ||||||||||||||||||||||||||||||||||||||||||
| Fiscal Period | Q4-FY2026 | Q3-FY2026 | Q2-FY2026 | Q1-FY2026 | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | ||||||||||||||||||||||||||||||||||||||||||
| Price to Sales | |||||||||||||||||||||||||||||||||||||||||||||||||
| Price to Book | .77x | .74x | .53x | 10.16x | .74x | 3.17x | 4.35x | ||||||||||||||||||||||||||||||||||||||||||
| Price to Earnings | 1.41x | 1.36x | .98x | 17.72x | 1.60x | - | - | ||||||||||||||||||||||||||||||||||||||||||
| Price to Unlevered FCF | - | - | - | - | - | ||||||||||||||||||||||||||||||||||||||||||||
| Debt to Asset Ratio | .11x | .13x | .13x | .52x | .85x | .50x | .86x | .63x | |||||||||||||||||||||||||||||||||||||||||
| Current Ratio | 9.33x | 7.38x | 8.56x | 1.92x | 1.16x | 1.88x | .82x | 1.12x | |||||||||||||||||||||||||||||||||||||||||